Inflammatory response in infective endocarditis

European Journal of Inflammation

Volumn 5, Issue 2, 2007, Pages 57-63

  Deviri, E ^a   Glenville, Brian E ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE   (Israel)

Author keywords

Blood culture negative endocarditis vegetation; Infective endocarditis; Inflammatory markers

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; FIBRONECTIN; GLUCOSYLTRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 10; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BLOOD CLOTTING; BLOOD CULTURE; COXIELLA BURNETII; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG ADMINISTRATION ROUTE; DRUG CHOICE; EARLY DIAGNOSIS; ENTEROCOCCUS FAECALIS; ERYTHROCYTE SEDIMENTATION RATE; HOST RESISTANCE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; Q FEVER; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS SANGUINIS; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 34548088709     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0700500201     Document Type: Review

References (45)

1. Osler W. 1885. The Gulstonian lectures on malignant endocarditis. BMJ 467:577.
2. Eric V., M.D. Granowitz, L. David and M.D. Longworth. 2003. Risk stratification and bedside prognostication in infective endocarditis JAMA 289: 1991.
3. Kay J.H., S. Bernstein, D. Feinstein and M. Biddle. 1961. Surgical cure of Candida albicans endocarditis with open-heart surgery. N. Engl. J. Med. 264:907.
4. Tlevieh I.M., J.M. Steckelberg, H.S. Murad, N.S. Anavekar, H.M.K. Ghomrawi, Z. Mirzoyev, S.E. Moustafa, T.L. Hoskin, J.N. Mandrekar, W.R. Wilson and L.M. Baddour. 2005. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293:3022.
5. Hasbun R., H.R. Vikram, L.A. Barakat, J. Buenconsejo and V.J. Quagliarello. 2003. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 289: 1933.
6. Raoult D., J.P. Casalta, H. Richet, M. Khan, E. Bernit, C. Rovery, S. Branger, F. Gouriet, G. Imbert, E. Bothello, F. Collart and G. Habib. 2005. Contribution of systematic serological testing in diagnosis of infective endocarditis. J. Clin. Microbiol. 43:5238.
7. Brown M. and G.E. Griffin. 1998. Immune responses in endocarditis. Heart 79:1.
8. Baddour L.M. 1994. Virulence factors among gram-positive bacteria in experimental endocarditis. Infect. Immun. 62:2143.
9. Garrison P.K. and L.R. Freedman. 1970. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J. Biol. Med. 42:394.
10. Durack D.T. and P.B. Besson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:44.
11. Drake T.A. and M. Pang. 1989. Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells. Infect. Immun. 57(2):507.
12. Veltrop M.H.A.M., H. Beekhuizen and J. Thompson. 1999. Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells. Infect. Immun. 67:6130.
13. Yeaman M.R., S.M. Puentes, D.C. Norman and A.S. Bayer. 1992. Partial characterization and staphylocidal activity of tbrombin-induced platelet microbicidal protein. Infect. Immun. 60:1202.
14. Kupferwasser L.I., M.R. Yeaman, S.M. Shapiro, C.C. Nast and A.S. Bayer. 2002. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental staphylococcus aureus endocarditis. Circulation 105:746.
15. Dhawan V.K., A.S. Bayer and M.R. Yeaman. 1998. In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental staphylococcus aureus infective endocarditis. Infect. Immun. 66:3476.
16. Mercier R.C., M.J. Rybak, A.S. Bayer and M.R. Yeaman. 2000. Influence of platelets and platelet microbicidal protein susceptibility on the fate of staphylococcus aureus in an in vitro model of infective endocarditis. Infect. Immun. 68:4699.
17. Dankert J., J. Krijgsveld, J. Van Der Werff, W. Joldersma and S.A. Zaat. 2001. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J. Infect. Dis. 184:597.
18. Veltrop M.H.A.M., J. Thompson and H. Beekhuizen. 2001. Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells. Infect. Immun. 69:2797.
19. Bancsi M.J., M.H.A.M. Veltrop, R.M. Bertina and J. Thompson. 1996. Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis. Infect. Immun. 64:448.
20. Veltrop M.H.A.M. and H. Beekhuizen. 2002. Monocytes maintain tissue factor activity after cytolysis of bacteria-infected endothelial cells in an in vitro model of bacterial endocarditis. J. Infect. Dis. 186:1145.
21. Bancsi M.J., M.H.A.M. Veltrop, R.M. Bertina and J. Thompson. 1996. Role of phagocytosis in activation of the coagulation system in Streptococcus sanguis endocarditis. Infect. Immun. 64:5166.
22. Veltrop M.H.A.M., J.A. Langermans, J. Thompson and M.J. Bancsi. 2001. Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis. Infect. Immun. 69:3197.
23. Durack D.T. and P.B. Besson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:50.
24. Hahn C.L., H.A. Schenkein and J.G. Tew. 2005. Endocarditis-associated oral streptococci promote rapid differentiation of monocytes into mature dendritic cells. Infect. Immun. 73:5015.
25. Cheung A.L., K.J. Eberhardt, E. Chung, M.R. Yeaman, P.M. Sullam, M. Ramos and A.S. Bayer. 1994. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Invest. 94:1815.
26. Toy P.T., L.W. Lai, T.A. Drake and M.A. Sande. 1985. Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect. Immun. 48:83.
27. Kuypers J.M. and R.A. Proctor. 1989. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect. Immun. 57:2306.
28. Cheung A.L., M.R. Yeaman, P.M. Sullam, M.D. Witt and A.S. Bayer. 1994. Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits. Infect. Immun. 62:1719.
29. Munro C.L. and F.L. Macrina. 1993. Sucrose-derived exopolysaccharides of Streptococcus mutans V403 contribute to infectivity in endocarditis. Mol. Microbiol. 8:133.
30. Shun C.T., S.Y. Lu, C.Y. Yeh, C.P. Chiang, J.S. Chia and J.Y. Chen. 2005. Glucosyltransferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis. Infect. Immun. 73:3261.
31. Yeh C.Y., J.Y. Chen and J.S. Chia. 2006. Glucosyltransferases of viridans group streptococci modulate interleukin-6 and adhesion molecule expression in endothelial cells and augment monocytic cell adherence. Infect. Immun. 74:1273.
32. Schlievert P.M., P.J. Gahr, A.P. Assimacopoulos, M.M. Dinges, J.A. Stoehr, J.W. Harmala, H. Hirt and G.M. Dunny. 1998. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect. Immun. 66:218.
33. Young L.S., J.O. Cisar, J.L. Bryant, M.A. Eckhaus and A.L. Sandberg. 2006. Resistance of Streptococcus gordonii to polymorphonuclear leukocyte killing is a potential virulence determinant of infective endocarditis. Infect. Immun. 74(6):3148.
34. Lamas C.C. and S.J. Eykyn. 2003. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 89:258.
35. Gouriet F., E. Bothelo-Nevers, B. Coulibaly, D. Raoult and J.P. Casalta. 2006. Evaluation of sedimentation rate, rheumatoid factor, C-reactive protein, and tumor necrosis factor for the diagnosis of infective endocarditis. Clin. Vaccine Immunol. 13: 301.
36. Rawczynska-Englert I., T. Hryniewiecki and D. Dzierzanowska. 2000. Evaluation of serum cytokine concentrations in patients with infective endocarditis. J. Heart Valve Dis. 9:705.
37. Alter P., J. Hoeschen, M. Ritter and B. Maisch. 2002. Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am. J. Cardiol. 89:1400.
38. Capo C., F. Zugun, A. Stein, G. Tardei, H. Lepidi, D. Raoult and J.L. Mege. 1996. Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis. Infect. Immun. 64:1638.
39. Dellacasagrande J., E. Ghigo, C. Capo, D. Raoult and J.L. Mege. 2000. Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factor. Infect. Immun. 68:160.
40. Dellacasagrande J., C. Capo, D. Raoult and J.L. Mege. 1999. IFN-gamma-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J. Immunol. 162:2259.
41. Ekdahl C., M. Broqvist, S. Franzen, O. Ljunghusen, R. Maller and B. Sander. 2002. IL-8 and tumor necrosis factor alpha in heart valves from patients with infective endocarditis. Scand. J. Infect. Dis. 34:759.
42. Hetzer R. and M. Hummell. 2001. Thromboembolism and endocarditis - it's not simply the vegetation. Eur. Heart J. 22:811.
43. Korkmaz S., M. Ileri, I. Hisar, E. Yetkin and F. Kosar. 2001. Increased levels of soluble adhesion molecules, E-selectin and P-selectin, in patients with infective endocarditis and embolic events. Eur. Heart J. 22:874.
44. Kupferwasser L.I., G. Hafner, S. Mohr-Kahaly, R. Erbel, J. Meyer and H. Darius. 1999. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J. Am. Coll. Cardiol. 33:1365.
45. Buyukasyk N.S., M. Ileri, A. Alper, K. Senen, R. Atak, I. Hisar, E. Yetkin, H. Turhan and D. Demirkan. 2004. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events. Clin. Cardiol. 27: 154.